• Razionale scientifico
    The Think Hadrom 2025: Neuro-Oncology event focuses on the use of hadrontherapy in the treatment of brain tumors, with a particular emphasis on low-grade gliomas, glioblastomas, and meningiomas. Hadrontherapy is an advanced radiotherapy modality that exploits the physical and radiobiological advantages of particles such as protons and carbon ions. In neuro-oncology the rational for increasing the use of hadrontherapy is to: -miminize the dose to neural structures in order to reduce the risk of toxicity and neurocognitive impairment -overcome the intrinsic radioresistance of aggressive tumors such as high grade meningiomas and glioblastomas, also improving the synergistic effect of radiotherapy and innovative systemic therapies -widen the therapeutic window in challenging cases as re-irradiation The sessions will cover advances in radiotherapy, integrated therapeutic strategies, and management of complications. This event gathers national and international experts to explore multidisciplinary approaches, optimize therapeutic protocols, and improve clinical outcomes in neuro-oncology.
    The meeting will be held in English.
    No simultaneous translation will be provided.

  • Modalità di partecipazione

    Per favorire la partecipazione, questo evento si svolgerà in forma ibrida. Sarà possibile seguire l’attività formativa in presenza presso la sede congressuale o in remoto.

    I due pulsanti sottostanti permettono di iscriversi secondo la modalità desiderata, fino ad esaurimento dei posti disponibili. L’iscrizione all’attività potrà avvenire esclusivamente attraverso procedura online, non saranno accettati nuovi iscritti presso la sede congressuale.

    ISCRIVITI al Corso Residenziale - PAVIA   ISCRIVITI all'Evento Digitale - ONLINE         

  • Programma dell’attività formativa

    9.30Introduction and course objectives
    		Alberto Iannalfi, Ester Orlandi
    Session I: Particle therapy in lower grade gliomas
    		Moderatori: Alberto Iannalfi, Ester Orlandi
    9.45Neurosurgical point of view
    		Giannantonio Spena
    10.05Overview on conventional RT
    		Giuseppe Minniti
    10.25Proton RT and neurocognitive sparing
    		Danielle B P Eekers
    10.45Systemic Therapy
    		Enrico Franceschi
    11.05Discussion
    		All the Speakers
    Session II: Particle Therapy in Glioblastomas
    		Moderatori: Sara Lillo, Ester Orlandi
    11.25Neurosurgical point of view
    		Alessandro Perin
    11.45Overview on conventional RT
    		Valentina Pinzi
    12.05Particle RT in newly diagnosed glioblastomas
    		Dan Trifiletti
    12.25Particle RT in recurrent glioblastomas
    		Alberto Iannalfi
    12.45Radio induced brain MRI alterations: diagnosis and management
    		Paola Bini
    13.05Systemic Therapy
    		Paola Gaviani
    13.25Discussion
    13.45Light Lunch
    14.45 Session III: Associations Experience
    		Association representetives
    Moderatori: Sara Lillo, Ester Orlandi
    Session IV. Particle therapy in meningiomas
    		Moderatori: Alberto Iannalfi, Ester Orlandi
    15.15Neurosurgical point of view
    		Francesco Doglietto
    15.35Particle therapy: protons and carbon ions
    		Sara Lillo
    15.55Molecular classifications to refine radiotherapeutic decision making
    16.15Systemic therapy
    		Giuseppe Lombardi
    16.35Discussion
    		All the Speakers
    16.55Closing Remarks
    		Alberto Iannalfi, Sara Lillo, Ester Orlandi
    17.00Adjourn

  • Faculty

    Alberto Iannalfi PaviaSara Lillo Pavia
    Ester Orlandi Pavia

    Paola Bini PaviaFrancesco Doglietto Roma
    Danielle B P Eekers Maastricht (Paesi Bassi)Enrico Franceschi Bologna
    Paola Gaviani MilanoAlberto Iannalfi Pavia
    Sara Lillo PaviaGiuseppe Lombardi Padova
    Giuseppe Minniti RomaEster Orlandi Pavia
    Alessandro Perin MilanoValentina Pinzi Milano
    Giannantonio Spena PaviaDan Trifiletti Jacksonville (Stati Uniti D'America)